$NIC
NICOLET BANKSHARES INC Stock $nic

$nic Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000117485023000018 Filed on May 02, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$92.06M	$87.38M
YoY Change	54.65%	50.86%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.077M	$4.197M
YoY Change	0.83%	-38.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$33.02M	$30.66M
YoY Change	643.31%	643.51%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$30.47M	-$13.09M
YoY Change	-4.55%	-141.04%
Income Tax	$7.878M	-$4.190M
% Of Pretax Income	25.85%
Net Earnings	$22.60M	-$8.898M
YoY Change	-5.8%	-136.82%
Net Earnings / Revenue	24.54%	-10.18%
Basic Earnings Per Share	$1.54	-$0.61
Diluted Earnings Per Share	$1.51	-$0.61
COMMON SHARES
Basic Shares Outstanding	14.72M shares	14.69M shares
Diluted Shares Outstanding	14.96M shares	14.69M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$505.2M	$114.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$117.3M	$112.6M
YoY Change	21.34%	19.4%
Goodwill	$367.4M	$367.4M
YoY Change	15.83%	15.83%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$8.483B	$8.192B
YoY Change	15.09%	11.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$58.81M	$54.54M
YoY Change	23.45%	18.98%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$50.00M	$50.00M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$108.8M	$104.5M
YoY Change	128.42%	128.06%
LONG-TERM LIABILITIES
Long-Term Debt	$197.6M	$197.4M
YoY Change	2.92%	2.87%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$197.6M	$197.4M
YoY Change	2.92%	2.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$108.8M	$104.5M
Total Long-Term Liabilities	$197.6M	$197.4M
Total Liabilities	$7.505B	$7.231B
YoY Change	14.92%	11.52%
SHAREHOLDERS EQUITY
Retained Earnings	$417.9M	$399.0M
YoY Change	15.51%	18.12%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$977.6M	$961.8M
YoY Change
Total Liabilities & Shareholders Equity	$8.483B	$8.192B
YoY Change	15.09%	11.91%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$22.60M	-$8.898M
YoY Change	-5.8%	-136.82%
Depreciation, Depletion And Amortization	$5.077M	$4.197M
YoY Change	0.83%	-38.0%
Cash From Operating Activities	$32.82M	$15.54M
YoY Change	19.8%	-29.17%
INVESTING ACTIVITIES
Capital Expenditures	$6.919M	$5.646M
YoY Change	-263.96%	-389.09%
Acquisitions
YoY Change
Other Investing Activities	$99.61M	$494.4M
YoY Change	-135.71%	578.49%
Cash From Investing Activities	$92.69M	$488.8M
YoY Change	-132.74%	589.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$28.00M
YoY Change		180.0%
Cash From Financing Activities	265.5M	-$544.9M
YoY Change	550.37%	86.46%
NET CHANGE
Cash From Operating Activities	32.82M	$15.54M
Cash From Investing Activities	92.69M	$488.8M
Cash From Financing Activities	265.5M	-$544.9M
Net Change In Cash	391.0M	-$40.54M
YoY Change	-281.95%	-79.66%
FREE CASH FLOW
Cash From Operating Activities	$32.82M	$15.54M
Capital Expenditures	$6.919M	$5.646M
Free Cash Flow	$25.91M	$9.896M
YoY Change	-18.07%	-58.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001174850
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37700
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	NICOLET BANKSHARES, INC
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WI
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-0871001
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	111 North Washington Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Green Bay,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WI
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	54301
CY2023Q1	dei	City Area Code CityAreaCode	(920)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	430-1400
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	NIC
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14716616	shares
CY2023Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	93462000	usd
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	121211000	usd
CY2023Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	20718000	usd
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	33512000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114180000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154723000	usd
CY2023Q1	nic	Time Deposit In Other Banks TimeDepositInOtherBanks	11293000	usd
CY2022Q4	nic	Time Deposit In Other Banks TimeDepositInOtherBanks	12518000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	1023176000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	917618000	usd
CY2023Q1	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	0	usd
CY2022Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	679128000	usd
CY2023Q1	us-gaap	Other Investments OtherInvestments	57482000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	65286000	usd
CY2023Q1	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	4962000	usd
CY2022Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	1482000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	6223732000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	6180499000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	62412000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	61829000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	6161320000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	6118670000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112569000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108956000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	166107000	usd
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	165137000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	400277000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	402438000	usd
CY2023Q1	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	140988000	usd
CY2022Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	138013000	usd
CY2023Q1	us-gaap	Assets Assets	8192354000	usd
CY2022Q4	us-gaap	Assets Assets	8763969000	usd
CY2023Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	2094623000	usd
CY2022Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	2361816000	usd
CY2023Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	4833956000	usd
CY2022Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	4817105000	usd
CY2023Q1	us-gaap	Deposits Deposits	6928579000	usd
CY2022Q4	us-gaap	Deposits Deposits	7178921000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	50000000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	317000000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	197448000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	225342000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	54535000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	70177000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	7230562000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7791440000	usd
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	147000	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	147000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	623746000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	621988000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	398966000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	407864000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-61067000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-57470000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	961792000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	972529000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8192354000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8763969000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14698265	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14690614	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14771255	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14764104	shares
CY2023Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	79142000	usd
CY2022Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	51299000	usd
CY2023Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	4961000	usd
CY2022Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	5127000	usd
CY2023Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1737000	usd
CY2022Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	675000	usd
CY2023Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1536000	usd
CY2022Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	817000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	87376000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	57918000	usd
CY2023Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	24937000	usd
CY2022Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2192000	usd
CY2023Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	3212000	usd
CY2022Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	0	usd
CY2023Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	2506000	usd
CY2022Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	1931000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	30655000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	4123000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	56721000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	53795000	usd
CY2023Q1	nic	Credit Loss Expense Reversal CreditLossExpenseReversal	3090000	usd
CY2022Q1	nic	Credit Loss Expense Reversal CreditLossExpenseReversal	300000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	53631000	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	53495000	usd
CY2023Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	1466000	usd
CY2022Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	3253000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	1200000	usd
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	933000	usd
CY2023Q1	nic	Deferred Compensation Plan Asset Market Valuations DeferredCompensationPlanAssetMarketValuations	946000	usd
CY2022Q1	nic	Deferred Compensation Plan Asset Market Valuations DeferredCompensationPlanAssetMarketValuations	-467000	usd
CY2023Q1	nic	Loan Servicing Right Income Net LoanServicingRightIncomeNet	1155000	usd
CY2022Q1	nic	Loan Servicing Right Income Net LoanServicingRightIncomeNet	-382000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-38468000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	1313000	usd
CY2023Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	1832000	usd
CY2022Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	1536000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	-21844000	usd
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	15943000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	24328000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	21191000	usd
CY2023Q1	nic	Occupancy Equipment And Office Expense OccupancyEquipmentAndOfficeExpense	8783000	usd
CY2022Q1	nic	Occupancy Equipment And Office Expense OccupancyEquipmentAndOfficeExpense	6944000	usd
CY2023Q1	us-gaap	Business Development BusinessDevelopment	2121000	usd
CY2022Q1	us-gaap	Business Development BusinessDevelopment	1831000	usd
CY2023Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	3988000	usd
CY2022Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	3387000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2161000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1424000	usd
CY2023Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	540000	usd
CY2022Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	480000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	163000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	98000	usd
CY2023Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2791000	usd
CY2022Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2195000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	44875000	usd
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	37550000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13088000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31888000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4190000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7724000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8898000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	24164000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.77
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14694451	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13648745	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14694451	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14214752	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8898000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	24164000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	15294000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-39948000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-213000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	15000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax	-20434000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1330000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-10790000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3597000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-29173000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12495000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5009000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	972529000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8898000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3597000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1424000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	148000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	186000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	961792000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	891891000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	24164000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-29173000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1799000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1887000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	175000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	54433000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	836310000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8898000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	24164000	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	4197000	usd
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	6769000	usd
CY2023Q1	nic	Credit Loss Expense Reversal CreditLossExpenseReversal	3090000	usd
CY2022Q1	nic	Credit Loss Expense Reversal CreditLossExpenseReversal	300000	usd
CY2023Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	1087000	usd
CY2022Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	933000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1424000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1799000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-38468000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	1313000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	612000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	2377000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	17789000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	86478000	usd
CY2023Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	20861000	usd
CY2022Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	88304000	usd
CY2023Q1	nic	Increase Decrease In Accrued Interest Receivable And Other Assets IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets	2326000	usd
CY2022Q1	nic	Increase Decrease In Accrued Interest Receivable And Other Assets IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets	-6786000	usd
CY2023Q1	nic	Increase Decrease In Interest Payable And Other Liabilities IncreaseDecreaseInInterestPayableAndOtherLiabilities	15642000	usd
CY2022Q1	nic	Increase Decrease In Interest Payable And Other Liabilities IncreaseDecreaseInInterestPayableAndOtherLiabilities	11426000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15542000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21943000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	41764000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	64669000	usd
CY2023Q1	nic	Increase Decrease In Certificates Of Deposit In Other Banks IncreaseDecreaseInCertificatesOfDepositInOtherBanks	-1225000	usd
CY2022Q1	nic	Increase Decrease In Certificates Of Deposit In Other Banks IncreaseDecreaseInCertificatesOfDepositInOtherBanks	-2228000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5017000	usd
CY2023Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2022Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	38856000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	22565000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3400000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	460051000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	0	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	42028000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	29511000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	2916000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	5430000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	3801000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	10953000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	11108000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	775000	usd
CY2023Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	117000	usd
CY2022Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	117000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5646000	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1953000	usd
CY2023Q1	nic	Payments For Proceeds From Other Real Estate And Other Assets PaymentsForProceedsFromOtherRealEstateAndOtherAssets	0	usd
CY2022Q1	nic	Payments For Proceeds From Other Real Estate And Other Assets PaymentsForProceedsFromOtherRealEstateAndOtherAssets	-3075000	usd
CY2023Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
CY2022Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	147833000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	488799000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	70921000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-250218000	usd
CY2022Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-229862000	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	267000000	usd
CY2022Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	28000000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	54433000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	186000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	175000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	148000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1887000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-544884000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-292233000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-40543000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-199369000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154723000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	595292000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114180000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	395923000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	30825000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	5170000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	nic	Debt Securities Available For Sale Transfer In From Held For Sale DebtSecuritiesAvailableForSaleTransferInFromHeldForSale	177727000	usd
CY2022Q1	nic	Debt Securities Available For Sale Transfer In From Held For Sale DebtSecuritiesAvailableForSaleTransferInFromHeldForSale	0	usd
CY2023Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	0	usd
CY2022Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	432000	usd
CY2023Q1	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	204000	usd
CY2022Q1	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	886000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1900000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and judgments that affect the amounts reported in the consolidated financial statements and accompanying disclosures. Estimates are used in accounting for, among other items, the allowance for credit losses, valuation of loans in acquisition transactions, useful lives for depreciation and amortization, fair value of financial instruments, impairment calculations, valuation of deferred tax assets, uncertain income tax positions and contingencies. These estimates are based on management’s knowledge of historical experience, current information, and other factors deemed to be relevant; accordingly, as this information changes, actual results could differ from those estimates. Factors that may cause sensitivity to the aforementioned estimates include but are not limited to: external market factors such as market interest rates and employment rates, changes to operating policies and procedures, changes in applicable banking or tax regulations, and changes to deferred tax estimates. Nicolet considers accounting estimates to be critical to reported financial results if the accounting estimate requires management to make assumptions about matters that are highly uncertain and different estimates that are reasonably likely to occur from period to period, could have a material impact on the financial statements. The accounting estimates we consider to be critical include business combinations and the valuation of loans acquired, the determination of the allowance for credit losses, and income taxes. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes or developments with respect to the assumptions or methodologies that the Company uses when applying critical accounting policies and developing critical accounting estimates as disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.</span></div>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the 2022 consolidated financial statements have been reclassified to conform to the 2023 presentation. These reclassifications were not material and did not impact previously reported net income or comprehensive income.</span></div>
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8898000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	24164000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14694000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13649000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	566000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14694000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14215000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.77
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	700000	shares
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	492	shares
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	136000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	78862000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1400000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1800000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	17200000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	100000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	400000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	1106829000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	728000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	84381000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	1023176000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	996344000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	917618000	usd
CY2022Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	679128000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	46000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	55822000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	623352000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	126000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	20000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	339000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	5000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-213000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	15000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	22565000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3400000	usd
CY2023Q1	nic	Debt Securities Held To Maturity Sold Realized Gain DebtSecuritiesHeldToMaturitySoldRealizedGain	0	usd
CY2022Q1	nic	Debt Securities Held To Maturity Sold Realized Gain DebtSecuritiesHeldToMaturitySoldRealizedGain	0	usd
CY2023Q1	nic	Debt Securities Held To Maturity Sold Realized Loss DebtSecuritiesHeldToMaturitySoldRealizedLoss	37723000	usd
CY2022Q1	nic	Debt Securities Held To Maturity Sold Realized Loss DebtSecuritiesHeldToMaturitySoldRealizedLoss	0	usd
CY2023Q1	us-gaap	Held To Maturity Securities Sold Security Realized Gain Loss HeldToMaturitySecuritiesSoldSecurityRealizedGainLoss	-37723000	usd
CY2022Q1	us-gaap	Held To Maturity Securities Sold Security Realized Gain Loss HeldToMaturitySecuritiesSoldSecurityRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	460051000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	0	usd
CY2023Q1	us-gaap	Restricted Investments RestrictedInvestments	414000000	usd
CY2022Q4	us-gaap	Restricted Investments RestrictedInvestments	883000000	usd
CY2023Q1	nic	Debt Securities Available For Sale And Held To Maturity Accrued Interest DebtSecuritiesAvailableForSaleAndHeldToMaturityAccruedInterest	6000000	usd
CY2022Q4	nic	Debt Securities Available For Sale And Held To Maturity Accrued Interest DebtSecuritiesAvailableForSaleAndHeldToMaturityAccruedInterest	6000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	187169000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	6595000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	754036000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	77786000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	941205000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	84381000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	1165	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	497072000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	35593000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	378520000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	43269000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	875592000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	78862000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	1296	security
CY2022Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	85699000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	9623000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	526583000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	46199000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	612282000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	55822000	usd
CY2022Q4	us-gaap	Held To Maturity Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions	170	security
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	2300000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	2300000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	225921000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	223243000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	173794000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	163788000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis	223776000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue	201296000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis	132626000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue	123228000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	756117000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	711555000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	1106829000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	1023176000	usd
CY2023Q1	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	32708000	usd
CY2022Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	32219000	usd
CY2023Q1	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	10174000	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	18625000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	3912000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	4376000	usd
CY2023Q1	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	10688000	usd
CY2022Q4	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	10066000	usd
CY2023Q1	us-gaap	Other Investments OtherInvestments	57482000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	65286000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	6223732000	usd
CY2023Q1	nic	Percentage Of Total Notes Receivable Gross PercentageOfTotalNotesReceivableGross	1
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	6180499000	usd
CY2022Q4	nic	Percentage Of Total Notes Receivable Gross PercentageOfTotalNotesReceivableGross	1
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	62412000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	61829000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	6161320000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	6118670000	usd
CY2023Q1	nic	Percentage Of Allowance For Credit Losses To Loans PercentageOfAllowanceForCreditLossesToLoans	0.0100
CY2022Q4	nic	Percentage Of Allowance For Credit Losses To Loans PercentageOfAllowanceForCreditLossesToLoans	0.0100
CY2023Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	16000000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	15000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	61829000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	49672000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	49672000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivableExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivableExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivableExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	1937000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	750000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	300000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	10950000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	184000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	100000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	1033000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	17000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	34000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	303000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery	167000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery	66000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery	730000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	62412000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	49906000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	61829000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	61829000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	750000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	184000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	17000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery	167000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	62412000	usd
CY2023Q1	nic	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss To Total Percent FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossToTotalPercent	1
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	49672000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivableExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	1937000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	10950000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	1033000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	303000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery	730000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	61829000	usd
CY2022	nic	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss To Total Percent FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossToTotalPercent	1
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACL-Loans represents management’s estimate of expected credit losses in the Company’s loan portfolio at the balance sheet date. To assess the appropriateness of the ACL-Loans, management applies an allocation methodology which focuses on evaluation of qualitative and environmental factors, including but not limited to: (i) evaluation of facts and issues related to specific loans; (ii) management’s ongoing review and grading of the loan portfolio; (iii) consideration of historical loan loss and delinquency experience on each portfolio segment; (iv) trends in past due and nonperforming loans; (v) the risk characteristics of the various loan segments; (vi) changes in the size and character of the loan portfolio; (vii) concentrations of loans to specific borrowers or industries; (viii) existing economic conditions; (ix) the fair value of underlying collateral; and (x) other qualitative and quantitative factors which could affect expected credit losses. Assessing these numerous factors involves significant judgment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management allocates the ACL-Loans by pools of risk within each loan portfolio segment. The allocation methodology consists of the following components. First, a specific reserve is established for individually evaluated credit-deteriorated loans, which management defines as nonaccrual credit relationships over $250,000, collateral dependent loans, purchased credit deteriorated loans, and other loans with evidence of credit deterioration. The specific reserve in the ACL-Loans for these credit </span></div>deteriorated loans is equal to the aggregate collateral or discounted cash flow shortfall. Management allocates the ACL-Loans with historical loss rates by loan segment. The loss factors are measured on a quarterly basis and applied to each loan segment based on current loan balances and projected for their expected remaining life. Next, management allocates the ACL-Loans using the qualitative factors mentioned above. Consideration is given to those current qualitative or environmental factors that are likely to cause estimated credit losses as of the evaluation date to differ from the historical loss experience of each loan segment. Lastly, management considers reasonable and supportable forecasts to assess the collectability of future cash flows.
CY2023Q1	nic	Material Loans Criteria For Acl Loans Adequacy Calculation MaterialLoansCriteriaForACLLoansAdequacyCalculation	250000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	3000000	usd
CY2022Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	3000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	750000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	300000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual Percent Past Due FinancingReceivableExcludingAccruedInterestNonaccrualPercentPastDue	0.006
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual Percent Past Due FinancingReceivableExcludingAccruedInterestNonaccrualPercentPastDue	0.006
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	10950000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	0	usd
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	0	usd
CY2022	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	550000	usd
CY2023Q1	nic	Debt Securities Available For Sale And Held To Maturity Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleAndHeldToMaturityCreditLossExpenseReversal	2340000	usd
CY2022Q1	nic	Debt Securities Available For Sale And Held To Maturity Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleAndHeldToMaturityCreditLossExpenseReversal	0	usd
CY2022	nic	Debt Securities Available For Sale And Held To Maturity Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleAndHeldToMaturityCreditLossExpenseReversal	0	usd
CY2023Q1	nic	Credit Loss Expense Reversal CreditLossExpenseReversal	3090000	usd
CY2022Q1	nic	Credit Loss Expense Reversal CreditLossExpenseReversal	300000	usd
CY2022	nic	Credit Loss Expense Reversal CreditLossExpenseReversal	11500000	usd
CY2023Q1	nic	Collateral Dependent Financing Receivable Unpaid Principal Balance CollateralDependentFinancingReceivableUnpaidPrincipalBalance	31953000	usd
CY2023Q1	nic	Collateral Dependent Financing Receivable With No Related Allowance CollateralDependentFinancingReceivableWithNoRelatedAllowance	24182000	usd
CY2023Q1	nic	Collateral Dependent Financing Receivable With Related Allowance CollateralDependentFinancingReceivableWithRelatedAllowance	7771000	usd
CY2023Q1	nic	Collateral Dependent Financing Receivable Related Allowance CollateralDependentFinancingReceivableRelatedAllowance	733000	usd
CY2022Q4	nic	Collateral Dependent Financing Receivable Unpaid Principal Balance CollateralDependentFinancingReceivableUnpaidPrincipalBalance	32072000	usd
CY2022Q4	nic	Collateral Dependent Financing Receivable With No Related Allowance CollateralDependentFinancingReceivableWithNoRelatedAllowance	22724000	usd
CY2022Q4	nic	Collateral Dependent Financing Receivable With Related Allowance CollateralDependentFinancingReceivableWithRelatedAllowance	9348000	usd
CY2022Q4	nic	Collateral Dependent Financing Receivable Related Allowance CollateralDependentFinancingReceivableRelatedAllowance	1121000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	6223732000	usd
CY2023Q1	nic	Percentage Of Loans By Past Due Status PercentageOfLoansByPastDueStatus	1.000
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	6180499000	usd
CY2022Q4	nic	Percentage Of Loans By Past Due Status PercentageOfLoansByPastDueStatus	1.000
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	38895000	usd
CY2023Q1	nic	Percentage Of Non Accrual Loan PercentageOfNonAccrualLoan	1
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	38080000	usd
CY2022Q4	nic	Percentage Of Non Accrual Loan PercentageOfNonAccrualLoan	1
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	154161000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1554581000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1257240000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	666231000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	420956000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	1292008000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	871982000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan	6573000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	6223732000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	1528490000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1271582000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	689302000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	437225000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	322275000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	1061537000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	864323000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan	5765000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	6180499000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Modified Period FinancingReceivableExcludingAccruedInterestModifiedPeriod	110000	usd
CY2023Q1	us-gaap	Financing Receivable Modification To Total Financing Receivables Excluding Accrued Interest Percent FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent	0
CY2022Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	18000000	usd
CY2022	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	24000000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	367387000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	367387000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32890000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	35051000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	400277000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	402438000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	367387000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	317189000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	49970000	usd
CY2023Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	usd
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	228000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	367387000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	367387000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	197448000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	225342000	usd
CY2022Q4	nic	Trust Preferred Securities Qualify As Tier1 Capital TrustPreferredSecuritiesQualifyAsTier1Capital	38000000	usd
CY2023Q1	nic	Trust Preferred Securities Qualify As Tier1 Capital TrustPreferredSecuritiesQualifyAsTier1Capital	38000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	100000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	100000	usd

Files In Submission

Name	View Source	Status
nic-20230331_pre.xml	Edgar Link	unprocessable
0001174850-23-000018-index-headers.html	Edgar Link	pending
0001174850-23-000018-index.html	Edgar Link	pending
0001174850-23-000018.txt	Edgar Link	pending
0001174850-23-000018-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nic-1q23x10qxex311.htm	Edgar Link	pending
nic-1q23x10qxex312.htm	Edgar Link	pending
nic-1q23x10qxex321.htm	Edgar Link	pending
nic-1q23x10qxex322.htm	Edgar Link	pending
nic-20230331.htm	Edgar Link	pending
nic-20230331.xsd	Edgar Link	pending
nic-20230331_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nic-20230331_cal.xml	Edgar Link	unprocessable
nic-20230331_def.xml	Edgar Link	unprocessable
nic-20230331_lab.xml	Edgar Link	unprocessable
nic-20230331_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NIC
NICOLET BANKSHARES INC Stock $nic

2023 Q2 Form 10-Q Financial Statement

#000117485023000018 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIC NICOLET BANKSHARES INC Stock $nic

2023 Q2 Form 10-Q Financial Statement

#000117485023000018 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIC
NICOLET BANKSHARES INC Stock $nic